Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: BRCA1 Mutation|Metastatic Breast Cancer
Interventions: DRUG: Cisplatin
Sponsor: Pomeranian Medical University Szczecin
Collaborators: Maria Sklodowska-Curie National Research Institute of Oncology